臺大醫院-腫瘤醫學部;臺大醫學院-癌症研究中心;Kim, Dong-WanDong-WanKimSoo, RossRossSooYang, James Chih-HsinJames Chih-HsinYangPark, KeunchilKeunchilParkStammberger, UzUzStammbergerXiong, HuiilingHuiilingXiongIhling, ChristianChristianIhlingWu, Yi-LongYi-LongWu2017-07-102018-07-072017-07-102018-07-072015http://ntur.lib.ntu.edu.tw//handle/246246/281036MSC2156119JEGFR mutationc-MettepotinibAntitumor Activity of Tepotinib plus Gefitinib in Asian Patients with Met plus EGFRm plus NSCLC